Canaccord Genuity Maintains Regeneron Pharmaceuticals (REGN) Hold Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 18, 2023, Canaccord Genuity maintained coverage of Regeneron Pharmaceuticals (NASDAQ:REGN) with a Hold recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2155522534-8510213a5205498c9cf10239a6d1542b.jpg "The 10 Best Alternatives to Craigslist")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1480323436-0009268132e143869758c3f6d2a4642b.jpg "<div>4 Basic Pointers When Investing Other People's Money</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1132711574-388eca9691b24bcea4b6ddac521bac25.jpg "Divorce Planning Checklist")
